Navigation Links
Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
Date:12/22/2010

SAN DIEGO and WOODCLIFF LAKE, N.J., Dec. 22, 2010 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

"The meeting discussions reinforce our position that we have a path forward to seek FDA approval of lorcaserin," said Jack Lief, Arena's President and Chief Executive Officer. "Based on guidance we have received from the agency, we are executing several activities and expect to resubmit the lorcaserin NDA by the end of 2011. As we continue discussions with the FDA to refine elements of our plan, we may identify ways to shorten this timeline. We will provide more details about our plan on the conference call and webcast this morning."

Arena submitted an NDA for lorcaserin to the FDA in December 2009, and the FDA issued a Complete Response Letter (CRL) in October 2010. In the CRL, the FDA outlined non-clinical and clinical reasons for its decision and provided recommendations relating to addressing such issues. The end-of-review meeting with the FDA included a discussion of the FDA's position on issues identified in the CRL and Arena's plan to respond.

Conference Call & Webcast Arena will host a conference call and webcast today, December 22, 2010, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to discuss its plan to address the CRL and resubmit the lorcaserin NDA. The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Lorcaserin" conference call. The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days fol
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
2. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
3. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
4. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
5. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
6. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
7. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
8. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
9. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
10. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
11. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... N.J. , March 6, 2015  Palatin Technologies, Inc. ... at the 27 th Annual ROTH Conference on Wednesday, ... will be held at the Ritz Carlton Laguna Niguel in ... Carl Spana , Ph.D., President and Chief Executive Officer ... and development programs. About Palatin Technologies, ...
(Date:3/6/2015)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: CNAT ).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On March 5, 2015, the Company abruptly announced in ...
(Date:3/6/2015)... , March 6, 2015  The onset of puberty ... as well as clumsier, and thus more inclined toward a ... during puberty, while the body,s center of gravity is altered. ... hands often grow more quickly than the rest of the ... of height in single year. And while these sudden changes ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Puberty can result in variety of athletic injuries 2
... PLAINFIELD, N.J., Dec. 22 PTC Therapeutics, Inc. (PTC) ... round was led by The Column Group - a new investor ... joined by current investors Credit Suisse First Boston, HBM BioVentures, Novo ... with the Delphi investment, general partner Deepa Pakianathan, Ph.D. will join ...
... Minn., Dec. 21 Envoy Medical, a Minnesota corporation, has ... the Esteem®. On December 18th, an Advisory Panel ... the Esteem®. , Patrick Spearman, Envoy Medical,s Chief ... for all sensorineural hearing loss sufferers. Envoy has been ...
Cached Medicine Technology:PTC Therapeutics Closes $50 Million Financing 2
(Date:3/6/2015)... 2015 Today, the California Healthcare Institute ... M.D., Ph.D., Director of the National Institutes of Health ... for a roundtable discussion regarding the vibrancy of the ... President Obama's Precision Medicine Initiative. , Joint Statement from ... Dean of the School of Medicine, UC San Diego; ...
(Date:3/6/2015)... Mediaplanet today announces distribution of its ... seeks to educate, encourage, and inspire women to take ... health and their health care rights. With gynecological cancer ... more pertinent to prioritize well-woman exams and stand up ... of “Women’s Health” is distributed within this weekend’s edition ...
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 Dr. ... has been seeking a ban on the use of power ... a recurrence of the cancer that prompted the launch of ... earlier this week that the 41-year-old mother of six ... the bony part in her spine. Dr. Reed had been ...
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... March 06, 2015 Sanjay Gupta, ... deliver a keynote address at ATA 2015, the ... and Trade Show and world’s largest telemedicine, telehealth ... neurosurgeon, delivers medical correspondence for several of CNN’s ... and documentaries including his DuPont Award winning WEED ...
Breaking Medicine News(10 mins):Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 2Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 3Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 2Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 3Health News:Power Morcellator News: Bernstein Liebhard LLP Comments on Report that Physician Working to Ban Uterine Morcellation Has Cancer Recurrence 4Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2
... In international study has found that people in their ... five years longer than those with hypertension or high ... had normal blood pressure developed heart disease later in ... has been published in the current issue of Hypertension: ...
... research had showed that patients who are depressed and ... having another heart attack is lessened considerably with the ... often treat clinical depression, also known as unipolar depression, ... SSRIs are a group of drugs that can increase ...
... have less back pain from osteoporosis related// curving of the ... special exercises. ,In a study presented by the researchers ... back support device can not only decrease the back pain ... women who had suffered the disease. ,Elderly population remains ...
... by the ‘Delhi High Court’ on Tuesday Justice Vikramjit Sen passed ... 12 year old for the wrong treatment administered by Dr ... the next few days how much compensation was the hospital ready ... indicated that the operation for total hip replacement and fixation of ...
... from Children's Hospital Boston suggests that a urine test ... anomalies. The study also raises the possibility of treating ... of the journal - Pediatrics, has published an article ... found in about 10% of newly born infants and ...
... who have television in their bedroom may score less in ... TV in their rooms. In a new study by the ... Stanford University researchers have reported that the home environment, especially ... their ability to affect the performance of children in school. ...
Cached Medicine News:Health News:Normal Blood Pressure Could Add Over 5 Years To Your Life 2Health News:Simple Urine Test Can Help To Monitor Disfiguring Birthmarks, 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Extremely fine straight....
Curved delicate 5 mm blades....
Medicine Products: